BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3116361)

  • 1. Heterogeneity of regional cerebral glucose metabolism demonstrated in situ in rat brain by 19F NMR rotating frame zeugmatography: one dimensional chemical shift imaging of normal and gliosarcoma implanted brain.
    Nakada T; Kwee IL
    Magn Reson Imaging; 1987; 5(4):259-66. PubMed ID: 3116361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive evaluation of effects of an aldose reductase inhibitor in rat brain by 19F FDG NMR spectroscopy.
    Nakada T; Kwee IL
    Magn Reson Med; 1987 Apr; 4(4):366-71. PubMed ID: 3108615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive demonstration of in vivo 3-fluoro-3-deoxy-D-glucose metabolism in rat brain by 19F nuclear magnetic resonance spectroscopy: suitable probe for monitoring cerebral aldose reductase activities.
    Kwee IL; Nakada T; Card PJ
    J Neurochem; 1987 Aug; 49(2):428-33. PubMed ID: 3110372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine-19 NMR imaging of glucose metabolism.
    Nakada T; Kwee IL; Card PJ; Matwiyoff NA; Griffey BV; Griffey RH
    Magn Reson Med; 1988 Mar; 6(3):307-13. PubMed ID: 3362066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase and sorbitol dehydrogenase activities in diabetic brain: in vivo kinetic studies using 19F 3-FDG NMR in rats.
    Kwee IL; Igarashi H; Nakada T
    Neuroreport; 1996 Feb; 7(3):726-8. PubMed ID: 8733731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive analysis of aldose reductase activities in rat testis: 3-FDG NMR spectroscopy and imaging.
    Nakada T; Kwee IL
    Magn Reson Med; 1993 Apr; 29(4):543-5. PubMed ID: 8464370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 31P and 3-fluoro-3-deoxy-D-glucose 19F in vivo NMR spectroscopy of aged rat brain.
    Kwee IL; Nakada T; Suzuki N
    NMR Biomed; 1991 Feb; 4(1):38-40. PubMed ID: 1903044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive in vivo demonstration of 2-fluoro-2-deoxy-D-glucose metabolism beyond the hexokinase reaction in rat brain by 19F nuclear magnetic resonance spectroscopy.
    Nakada T; Kwee IL; Conboy CB
    J Neurochem; 1986 Jan; 46(1):198-201. PubMed ID: 3940280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo metabolism of 3-deoxy-3-fluoro-D-glucose.
    Berkowitz BA; Moriyama T; Fales HM; Byrd RA; Balaban RS
    J Biol Chem; 1990 Jul; 265(21):12417-23. PubMed ID: 2115519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-19 MR imaging of glucose metabolism in the rabbit.
    Nakada T; Kwee IL; Griffey BV; Griffey RH
    Radiology; 1988 Sep; 168(3):823-5. PubMed ID: 3136509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-FG as substrate for investigating flux through the polyol pathway in dog lens by 19F-NMR spectroscopy.
    Lizak MJ; Secchi EF; Lee JW; Sato S; Kubo E; Akagi Y; Kador PF
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2688-95. PubMed ID: 9856779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 19F 2-FDG NMR imaging of the brain in rat.
    Nakada T; Kwee IL; Griffey BV; Griffey RH
    Magn Reson Imaging; 1988; 6(6):633-5. PubMed ID: 3210906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 19F NMR quantitation of lens aldose reductase activity using 3-deoxy-3-fluoro-D-glucose.
    Karino K; Kador PF; Berkowitz B; Balaban RS
    J Biol Chem; 1991 Nov; 266(31):20970-5. PubMed ID: 1939148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-dimensional chemical shift imaging of fluorinated neuroleptics in rat brain in vivo by 19F NMR rotating frame zeugmatography.
    Nakada T; Kwee IL
    Magn Reson Imaging; 1989; 7(5):543-5. PubMed ID: 2575203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of energy metabolism in brain using epimerization of 2-deoxy-2-fluoro-D-glucose by 19F NMR: the effect of anesthesia.
    Shinohara S; Kanazawa Y; Kojima M
    Magn Reson Med; 1991 Oct; 21(2):191-6. PubMed ID: 1745118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral metabolism of fluorodeoxyglucose measured with 19F NMR spectroscopy.
    Pouremad R; Wyrwicz AM
    NMR Biomed; 1991 Aug; 4(4):161-6. PubMed ID: 1931555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Deoxy-2-fluoro-D-glucose as a functional probe for NMR: the unique metabolism beyond its 6-phosphate.
    Kanazawa Y; Yamane H; Shinohara S; Kuribayashi S; Momozono Y; Yamato Y; Kojima M; Masuda K
    J Neurochem; 1996 May; 66(5):2113-20. PubMed ID: 8780043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton decoupled fluorine nuclear magnetic resonance spectroscopy in situ.
    Berkowitz BA; Ackerman JJ
    Biophys J; 1987 Apr; 51(4):681-5. PubMed ID: 3034345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of rates of local cerebral glucose utilization determined with deoxy[1-14C]glucose and deoxy[6-14C]glucose.
    Dienel GA; Cruz NF; Nakanishi H; Melzer P; Moulis P; Sokoloff L
    J Neurochem; 1992 Oct; 59(4):1430-6. PubMed ID: 1402893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 19F NMR of 2-deoxy-2-fluoro-D-glucose for tumor diagnosis in mice. An NDP-bound hexose analog as a new NMR target for imaging.
    Kanazawa Y; Umayahara K; Shimmura T; Yamashita T
    NMR Biomed; 1997 Jan; 10(1):35-41. PubMed ID: 9251114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.